Diverse toll-like receptors mediate cytokine production by fusobacterium nucleatum and aggregatibacter actinomycetemcomitans in macrophages

Infection and Immunity

Volumn 82, Issue 5, 2014, Pages 1914-1920

  Park, Se Ra ^a   Kim, Dong Jae ^b   Han, Seung Hyun ^c   Kang, Min Jung ^b   Lee, Jun Young ^b   Jeong, Yu Jin ^b   Lee, Sang Jin ^b   Kim, Tae Hyoun ^d   Ahn, Sang Gun ^a   Yoon, Jung Hoon ^e   Park, Jong Hwan ^b  

^a Chosun University   (South Korea)

^b Konyang University   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University   (South Korea)

^e Wonkwang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME KINETICS; FUSOBACTERIUM INFECTION; FUSOBACTERIUM NUCLEATUM; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NONHUMAN; PASTEURELLACEAE INFECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANIMALS; CYTOKINES; FUSOBACTERIUM INFECTIONS; FUSOBACTERIUM NUCLEATUM; GENE EXPRESSION REGULATION; MACROPHAGES; MICE; MICE, KNOCKOUT; PASTEURELLACEAE INFECTIONS; TOLL-LIKE RECEPTORS;

EID: 84898868970     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01226-13     Document Type: Article

References (31)

1. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11:373-384. http://dx.doi.org/10.1038/ni.1863.
2. Nishihara T, Koseki T. 2004. Microbial etiology of periodontitis. Periodontol. 2000 36:14-26. http://dx.doi.org/10.1111/j.1600-0757.2004.03671.x.
3. Slots J, Reynolds HS, Genco RJ. 1980. Actinobacillus actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation. Infect. Immun. 29:1013-1020.
4. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL, Jr. 1998. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25:134-144. http://dx.doi.org/10.1111/j.1600-051X.1998.tb02419.x.
5. Kikkert R, Laine ML, Aarden LA, van Winkelhoff AJ. 2007. Activation of toll-like receptors 2 and 4 by gram-negative periodontal bacteria. Oral Microbiol. Immunol. 22:145-151. http://dx.doi.org/10.1111/j.1399-302X.2007.00335.x.
6. Sun Y, Shu R, Li CL, Zhang MZ. 2010. Gram-negative periodontal bacteria induce the activation of Toll-like receptors 2 and 4, and cytokine production in human periodontal ligament cells. J. Periodontol. 81:1488-1496. http://dx.doi.org/10.1902/jop.2010.100004.
7. Talati AJ, Kim HJ, Kim YI, Yi AK, English BK. 2008. Role of bacterial DNA in macrophage activation by group B streptococci. Microbes Infect. 10:1106-1113. http://dx.doi.org/10.1016/j.micinf.2008.06.001.
8. Gonzalez OA, Li M, Ebersole JL, Huang CB. 2010. HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages. Clin. Vaccine Immunol. 17:1417-1427. http://dx.doi.org/10.1128/CVI.00009-10.
9. Celada A, Gray PW, Rinderknecht E, Schreiber R. 1984. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J. Exp. Med. 160:55-74. http://dx.doi.org/10.1084/jem.160.1.55.
10. Kuznik A, Bencina M, Svajger U, Jeras M, Rozman B, Jerala R. 2011. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. J. Immunol. 186:4794-4804. http://dx.doi.org/10.4049 /jimmunol.1000702.
11. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801. http://dx.doi.org/10.1016/j.cell.2006.02.015.
12. Kawai T, Akira S. 2006. TLR signaling. Cell Death Differ. 13:816-825. http://dx.doi.org/10.1038/sj.cdd.4401850.
13. Marcato LG, Ferlini AP, Bonfim RC, Ramos-Jorge ML, Ropert C, Afonso LF, Vieira LQ, Sobrinho AP. 2008. The role of Toll-like receptors 2 and 4 on reactive oxygen species and nitric oxide production by macrophage cells stimulated with root canal pathogens. Oral Microbiol. Immunol. 23:353-359. http://dx.doi.org/10.1111/j.1399-302X.2008.00432.x.
14. Tietze K, Dalpke A, Morath S, Mutters R, Heeg K, Nonnenmacher C. 2006. Differences in innate immune responses upon stimulation with gram-positive and gram-negative bacteria. J. Periodontal Res. 41:447-454. http://dx.doi.org/10.1111/j.1600-0765.2006.00890.x.
15. Beutler B, Poltorak A. 2001. The sole gateway to endotoxin response: how LPS was identified as Tlr4, and its role in innate immunity. Drug Metab. Dispos. 29:474-478.
16. Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. 2009. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458:1191-1195. http://dx.doi.org/10.1038/nature07830.
17. Akashi S, Nagai Y, Ogata H, Oikawa M, Fukase K, Kusumoto S, Kawasaki K, Nishijima M, Hayashi S, Kimoto M. 2001. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int. Immunol. 13:1595-1599. http://dx.doi.org/10.1093 /intimm/13.12.1595.
18. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI. 2002. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3:354-359. http://dx.doi.org/10.1038/ni777.
19. Bäckhed F, Normark S, Schweda EKH, Oscarson S, Richter-Dahlfors A. 2003. Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications. Microbes Infect. 5:1057-1063. http://dx.doi.org/10.1016/S1286-4579(03)00207-7.
20. Asai Y, Makimura Y, Kawabata A, Ogawa T. 2007. Soluble CD14 discriminates slight structural differences between lipid as that lead to distinct host cell activation. J. Immunol. 179:7674-7683.
21. Jain S, Darveau RP. 2010. Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis. Periodontol. 2000 54:53-70. http://dx.doi.org/10.1111/j.1600-0757.2009.00333.x.
22. Ogawa T, Uchida H. 1996. Differential induction of IL-1 beta and IL-6 production by the nontoxic lipidAfrom Porphyromonas gingivalis in comparison with synthetic Escherichia coli lipid A in human peripheral blood mononuclear cells. FEMS Immunol. Med. Microbiol. 14:1-13. http://dx.doi.org/10.1111/j.1574-695X.1996.tb00261.x.
23. Martin M, Katz J, Vogel SN, Michalek SM. 2001. Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J. Immunol. 167:5278-5285.
24. Li Q, Verma IM. 2002. NF-κB regulation in the immune system. Nat. Rev. Immunol. 2:725-734. http://dx.doi.org/10.1038/nri910.
25. Johnson GL, Lapadat R. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911. http://dx.doi.org/10.1126/science.1072682.
26. Ghosh SK, Gupta S, Jiang B, Weinberg A. 2011. Fusobacterium nucleatum and human beta-defensins modulate the release of antimicrobial chemokine CCL20/macrophage inflammatory protein 3α. Infect. Immun. 79:4578-4587. http://dx.doi.org/10.1128/IAI.05586-11.
27. Uitto VJ, Baillie D, Wu Q, Gendron R, Grenier D, Putnins EE, Kanervo A, Firth JD. 2005. Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells. Infect. Immun. 73:1171-1179. http://dx.doi.org/10.1128/IAI.73.2.1171-1179.2005.
28. Krisanaprakornkit S, Kimball JR, Dale BA. 2002. Regulation of human beta-defensin-2 in gingival epithelial cells: the involvement of mitogenactivated protein kinase pathways, but not the NF-κB transcription factor family. J. Immunol. 168:316-324.
29. Chung WO, Dale BA. 2004. Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect. Immun. 72:352-358. http://dx.doi.org/10.1128/IAI.72.1.352-358.2004.
30. Stacey KJ, Sweet MJ, Hume DA. 1996. Macrophages ingest and are activated by bacterial DNA. J. Immunol. 157:2116-2122.
31. Suzuki K, Suda T, Naito T, Ide K, Chida K, Nakamura H. 2005. Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA. Am. J. Respir. Crit. Care Med. 171:707-713. http: //dx.doi.org/10.1164/rccm.200408-1078OC.